Kenner C Rice Selected Research

Injections

10/2017	Hypothalamic CRF1 receptor mechanisms are not sufficient to account for binge-like palatable food consumption in female rats.
8/2014	Role of bed nucleus of the stria terminalis corticotrophin-releasing factor receptors in frustration stress-induced binge-like palatable food consumption in female rats with a history of food restriction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenner C Rice Research Topics

Disease

41	Pain (Aches) 04/2024 - 01/2003
26	Hyperalgesia 04/2022 - 03/2006
20	Substance-Related Disorders (Drug Abuse) 03/2024 - 01/2004
11	Alcoholism (Alcohol Abuse) 01/2023 - 12/2007
11	Opioid-Related Disorders (Opiate Addiction) 02/2022 - 01/2003
11	Neuralgia (Stump Neuralgia) 01/2022 - 11/2007
11	Inflammation (Inflammations) 01/2021 - 06/2002
7	Obesity 01/2018 - 01/2004
7	Cocaine-Related Disorders (Cocaine Addiction) 03/2016 - 03/2002
6	Memory Disorders (Memory Loss) 03/2024 - 01/2018
6	Hyperthermia 01/2022 - 05/2004
6	Chronic Pain 05/2021 - 03/2006
6	Body Weight (Weight, Body) 01/2018 - 08/2012
6	Hypersensitivity (Allergy) 01/2018 - 03/2006
5	Respiratory Insufficiency (Respiratory Failure) 04/2024 - 11/2009
4	Neuroinflammatory Diseases 04/2022 - 01/2019
4	Infections 11/2019 - 01/2003
4	Seizures (Absence Seizure) 01/2019 - 02/2006
4	Neoplasms (Cancer) 01/2018 - 11/2005
4	Acute Pain 02/2015 - 07/2005
3	Premature Birth (Birth, Premature) 04/2020 - 11/2016
3	Weight Loss (Weight Reduction) 01/2019 - 06/2002
3	Schizophrenia (Dementia Praecox) 01/2018 - 09/2002
3	Bulimia (Binge Eating) 10/2017 - 09/2012
3	Feeding and Eating Disorders (Eating Disorder) 10/2017 - 01/2004
2	Tetanus 12/2023 - 06/2021
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 01/2021
2	Peripheral Nerve Injuries 01/2022 - 01/2018
2	Fetal Death 01/2020 - 11/2016
2	Perinatal Death 01/2020 - 11/2016
2	Autistic Disorder (Autism) 01/2019 - 09/2009

Drug/Important Bio-Agent (IBA)

34	Opioid Analgesics (Opioids)IBA 04/2024 - 09/2002
18	Morphine (MS Contin)FDA LinkGeneric 09/2022 - 01/2003
15	Analgesics (Analgesic Drugs)IBA 04/2024 - 11/2005
13	Toll-Like Receptor 4IBA 01/2021 - 07/2008
11	Naltrexone (ReVia)FDA LinkGeneric 01/2021 - 07/2008
10	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 05/2006
10	Opioid Receptors (Opioid Receptor)IBA 04/2022 - 03/2006
10	Serotonin (5 Hydroxytryptamine)IBA 01/2018 - 09/2009
8	Ethanol (Ethyl Alcohol)IBA 01/2021 - 01/2009
8	4- (alpha- (4- allyl- 2,5- dimethyl- 1- piperazinyl)- 3- methoxybenzyl)- N,N- diethylbenzamideIBA 01/2020 - 11/2005
7	Synthetic CathinoneIBA 03/2024 - 11/2014
7	VaccinesIBA 02/2022 - 09/2014
7	Naloxone (Narcan)FDA LinkGeneric 04/2020 - 07/2008
6	Fentanyl (Sublimaze)FDA LinkGeneric 04/2024 - 04/2014
6	Cocaine (Cocaine HCl)IBA 03/2024 - 10/2006
6	Heroin (Diamorphine)IBA 12/2023 - 01/2017
6	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 01/2019 - 04/2005
6	Interleukin-6 (Interleukin 6)IBA 01/2018 - 08/2007
5	LigandsIBA 10/2021 - 03/2002
5	R 121919IBA 01/2018 - 04/2009
5	Corticotropin-Releasing HormoneIBA 01/2016 - 06/2002
4	AcidsIBA 04/2024 - 10/2010
4	Minocycline (Cyclops)FDA LinkGeneric 04/2022 - 10/2014
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2016
4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 11/2007
4	Methadone (Dolophine)FDA LinkGeneric 11/2020 - 01/2012
4	Narcotic Antagonists (Opioid Antagonists)IBA 04/2020 - 07/2008
4	volinanserinIBA 01/2019 - 05/2004
4	antalarminIBA 01/2018 - 06/2002
4	Nalbuphine (Nubain)FDA LinkGeneric 01/2018 - 11/2010
4	Capsaicin (Zostrix)FDA Link 01/2018 - 09/2008
4	CRF receptor type 1IBA 10/2017 - 12/2007
3	AntibodiesIBA 12/2023 - 09/2014
3	InflammasomesIBA 04/2022 - 01/2016
3	HaptensIBA 02/2022 - 02/2016
3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2021
3	Dynorphins (Dynorphin)IBA 05/2021 - 03/2006
3	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2020 - 01/2017
3	CytokinesIBA 11/2019 - 08/2007
3	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2019 - 05/2004
3	NeuropeptidesIBA 01/2018 - 11/2012
3	lorcaserinIBA 01/2018 - 12/2015
3	CorticosteroneIBA 01/2018 - 06/2002
3	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 10/2017 - 01/2004
3	RimonabantIBA 10/2014 - 11/2013
3	CannabinoidsIBA 09/2014 - 11/2013
3	GABA-B ReceptorsIBA 03/2013 - 10/2010
3	delta Opioid Receptors (delta Opioid Receptor)IBA 04/2012 - 11/2005
3	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2007 - 03/2002
2	mu Opioid Receptors (mu Opioid Receptor)IBA 04/2024 - 01/2018
2	Caffeine (No Doz)FDA LinkGeneric 03/2024 - 01/2024
2	Ghrelin ReceptorsIBA 01/2023 - 11/2021
2	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 04/2022 - 01/2022
2	NLR ProteinsIBA 01/2022 - 01/2016
2	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022 - 01/2021
2	norbinaltorphimineIBA 05/2021 - 06/2010
2	Sigma-1 ReceptorIBA 01/2021 - 01/2015
2	1- (2- (3,4- dichlorophenyl)ethyl)- 4- methylpiperazineIBA 01/2021 - 01/2015
2	Messenger RNA (mRNA)IBA 01/2021 - 02/2006
2	Toll-Like Receptor 2IBA 01/2021 - 05/2012
2	Platelet Activating FactorIBA 04/2020 - 01/2020
2	Amphetamine (Amfetamine)FDA LinkGeneric 01/2019 - 04/2005
2	Oxycodone (Oxycontin)FDA LinkGeneric 01/2018 - 02/2016
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2018 - 08/2013
2	SaltsIBA 01/2018 - 04/2015

Therapy/Procedure

8	Therapeutics 01/2023 - 01/2007
6	Analgesia 04/2022 - 11/2007
5	Self Administration (Administration, Self) 03/2024 - 12/2007
2	Spinal Injections 01/2022 - 05/2013